Is US Physicalrapy Inc (USPH) overvalued? · P/E 34, rev $671.3M
US Physicalrapy Inc (USPH) is a medical care facilities company listed on US.
This page asks whether US Physicalrapy Inc (USPH) looks expensive on cached numbers — not a short thesis.
Latest reported USPH revenue for 2024-12-31 was $671.3M. Net income was $45.6M. Revenue was up 11.0% from 2023-12-31 to 2024-12-31. USPH currently screens at market cap $1.13B and trailing P/E 34.2.
USPH currently screens at market cap $1.13B and trailing P/E 34.2. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next USPH 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the USPH stock page for the full model, not this heading.
Not investment advice.